Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	25.38	161.28	128.64
Graham Fair Price	-10.50	16.38	18.31
PEG	58.42	-2.10	1.32
Price/Book	-7.11	13.57	14.61
Price/Cash Flow	13.89	237.81	208.81
Prices/Earnings	27.32	48.89	38.39
Price/Sales	3.09	47.99	46.55
Price/FCF	13.89	237.81	208.81
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-2.95	0.88	0.90
Operating Margin	-21.34	0.25	0.31
ROA	-24.25	0.04	0.06
ROE	0.10	0.07	-27.04
ROIC	0.07	0.05	-34.44
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.15	0.18	-15.50
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.15	-0.26	72.73
EPS QOQ	0.29	-0.23	-19.63
FCF QOQ	-0.36	-0.15	59.99
Revenue QOQ	0.04	-0.06	25.16
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	157.06	133.55	-14.96
Days Sales Outstanding (DSO)	41.20	34.77	-15.61
Inventory Turnover	0.57	0.67	17.60
Debt/Capitalization	0.18	0.15	-16.03
Quick Ratio	1.02	1.06	3.15
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	12.51	13.11	4.78
Cash	4.18	4.25	1.61
Capex	-0.12	-0.18	-46.43
Free Cash Flow	0.88	0.75	-14.53
Revenue	3.93	3.71	-5.58
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.24	1.32	5.99
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.63	-1.22	-92.37
Naive Interpretation	Member

06 - Financial Health · Weak

Rating